casopitant: Clinical Trials

6 trials of casopitant, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 withdrawn. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Completed 5, Withdrawn 1

Follow casopitant: new trials by email Literature Review of casopitant trials Research Report on casopitant

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
Dexamethasone, IV casopitant (placebo), IV casopitant (active) - Cancer, Chemotherapy-Induced Nausea and Vomiting
Phase 3WithdrawnGlaxoSmithKline2009-09-012015-04-17
A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
Casopitant, Dexamethasone, Placebo - Nausea and Vomiting, Chemotherapy-Induced
Phase 3CompletedGlaxoSmithKline7102008-03-102018-01-17
A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy
Oral Casopitant (GW679769), IV Casopitant (GW679769), IV ondansetron hydrochloride - Nausea and Vomiting, Chemotherapy-Induced
Phase 3CompletedGlaxoSmithKline8102006-11-062017-08-22
Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting
Casopitant (GW679769) oral tablets, Casopitant (GW679769) intravenous, Dexamethasone intravenous - Vomiting, Nausea
Phase 3CompletedGlaxoSmithKline18402006-07-012012-09-10
Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women
GW679769 (casopitant) - Nausea and Vomiting, Postoperative
Phase 3CompletedGlaxoSmithKline4822006-03-012016-10-26
Casopitant And ZOFRAN To Prevent Post Operative Nausea And Vomiting In Women
casopitant - Nausea and Vomiting, Postoperative, Postoperative Nausea and Vomiting
Phase 3CompletedGlaxoSmithKline5152006-03-012017-03-23

Conditions studied

Nausea (4)  ·  Vomiting (4)  ·  Postoperative Nausea and Vomiting (2)  ·  Colorectal Neoplasms (1)  ·  Lung Neoplasms (1)  ·  Neoplasms (1)

Sponsors

GlaxoSmithKline (6)

Countries

Canada (5)  ·  United States (5)  ·  Belgium (4)  ·  Czechia (4)  ·  Germany (4)  ·  Hungary (4)  ·  Pakistan (4)  ·  Philippines (4)  ·  Thailand (4)  ·  Bulgaria (3)  ·  Hong Kong (3)  ·  Ireland (3)  ·  Italy (3)  ·  Russia (3)  ·  Slovakia (3)

Results publications

PMID 19428297, PMID 19805683